Pharmacotherapy of depression and bipolar disorder Flashcards
Drug interactions with antidepressants
MAO-Is, serotonin syndrome may result
Prototype SSRIs
Fluoxetine (Prozac), Sertaline (Zoloft)
MOA of SSRIs
blocks 5-HT reuptake, increased neurotransmitter in cleft
Therapeutic use of SSRIs
MDD, anxiety
Pharmacokinetics of SSRIs
First pass metabolism, active metabolites
well absorbed
requires 5-6 weeks to reach steady state
complete wash out in 5-6 weeks
Side effects of SSRIs
initial anxiety
agitation
sexual dysfunction
Toxicity of SSRIs
agitation, vomiting, seizure
pregnancy C-persistant pulmonary hypertension in newborns
Drug interactions with SSRIs
Inhibits CYP 2D6- Tomoxifen for breast cancer
Drugs that prolong QT interval
Advantages of sertraline
better tolerated, widely prescribed
Prototyped SNRI
Duloxetine (cymbalta)
MOA of SNRI
both seratonin and norepinephrine reuptake inhibited
Therapeutic use of SNRI
MDD
anxiety
some types of chronic pain
Pharmacokinetics of duloxetine
Well absorbed-food slows absorption
metabolixed by 2D6
half life 11-12 hrs
Side effects of duloxetine
headache, somnolence, fatigue, insomnia
nausea, dry mouth, constipation, diarrhea
some chance of liver damage
Drug interactions of duloxetine
Drugs using NET for their action- methyldopa, monoxidil
CYP 1A2 and 2D6 inhibitors
MAO inhibitors- seretonin syndrome
Contraindications of duloxetine
MAO inhibitors
Narrow angle glaucoma
Prototype TCA
Amitriptyline
MOA of TCA
block 5HT and NE, many non-specific actions.
Pharmacokinetics of amitriptyline
well absorbed, oral admin
metabolized by CYP 2D6
metabolized to active metabolites
half life 30 hrs
Therapeutic use of amitriptyline
MDD
off label pain
Muscarinic side effects of amitriptyline
tachycardia
Alpha-1 adrenergic inhibition side effects of amitriptyline
orthostatic hypotension
Antihistamine H1 antagonism side effects of amitriptyline
sedation, weight gain
5HT2 side effects of amitriptyline
sexual dysfunction
Toxicity of TCAs
acute poisoning life threatening,
seizures, severe cardiac toxicity
Drug interactions with amitriptyline
serotonin syndrome
drugs that prolong Q-T interval
Can reverse antihypertensive effects
MAOI prototype
phenelzine
MOA of phenelzine
irreverrsible inhibiton of monamine oxidase MAO A and B, A is responsible for therapeutic effect
Therapeutic use of MAOIs
Major depressive disorder, when others have failed
Contraindications with TCAs
pre-exisiting cardiovascular effects
Therapeutic use of lithium
bipolar disorder
Pharmacokinetics of lithium
excretion is reduced when sodium is low
low therapeutic index
Adverse effects of lithium
hand tremors, ataxia, seizures, arrhythmias, coma
Adverse effects of MAOIs
orthostatic hypotension
sedation
Food and drug interactions with MAOIs
tyramine
sympathomimetic amines
antidepressents
CNS depressants
Toxicity of MAOIs
CNS stimulation, not lethal